Choosing to participate in a study is an important decision we encourage you to discuss with your family members and friends. Every study comes with potential risks and benefits you should talk about with your doctors and study coordinators.
Featured studies:
- FSR Patient Registry
- Xentria: XTMAB-16 Phase 2
- Molecure: The KITE Study Phase 2
- Avalyn Pharma: The MIST Study Phase 2b
- Detection and Characterization of Host Defense Defects Clinical Trial
- Sarcoidosis Biobanking Study
- University of Utah Health Neurology Survey Study
- REPAIR-CS Study for Cardiac Sarcoidosis
You can stay informed about new sarcoidosis studies by signing up for regular updates through our SARConnect Study Newsletter below.
We also encourage you to read the FSR Research Report, which provides exciting updates and developments from the FSR Research Team. Visit FSR Updates to read publications, posters, abstracts, and more to stay up to date on sarcoidosis research.
In 2024, FSR received a letter of clarification from the DOL that ensures employee access to FMLA benefits when participating in clinical trials. Learn more here.
The opportunity to accelerate research is in your hands.